Gemma Brown Terminated As CFO Effective April 30, 2025 - SEC Filing
07/05/2025 13:20
Barinthus Biotherapeutics PLC 2ABy.F: BARINTHUS BIOTHERAPEUTICS PLC - GEMMA BROWN TERMINATED AS CFO EFFECTIVE APRIL 30, 2025 - SEC FILING BARINTHUS BIOTHERAPEUTICS PLC - WILLIAM ENRIGHT APPOINTED AS PRINCIPAL FINANCIAL OFFICER BARINTHUS BIOTHERAPEUTICS PLC - GEMMA BROWN TO TRANSITION TO CONSULTANT ROLE Source text: [ID:n0001828185-25-000036] Further company coverage: [2ABy.F]
Recent news on Barinthus Biotherapeutics
See all newsBrief: Barinthus Bio Provides Update On Proposed Combination With Clywedog Therapeutics
Brief: Barinthus Biotherapeutics PLC Appoints Douglas Swirsky As CFO And Principal Accounting Officer Effective May 1, 2026
Brief: Barinthus Bio Announces Update On Phase 1 AVALON Clinical Trial Of VTP-1000 For The Treatment Of Celiac Disease
Brief: Barinthus Bio Reports Second Quarter 2025 Financial Results And Updates On Corporate Developments
Gemma Brown Terminated As CFO Effective April 30, 2025 - SEC Filing